In non-critically ill COVID-19 patients, pneumonia treated with high-dose methylprednisolone showed lower C-reactive protein (CRP), and D-dimer compared to high-dose dexamethasone [1]. This evidence concerns the gene CRP and susceptibility to pneumonia measurement.